CLYM

CLIMB BIO INC

CLYM·28658R106·US·Common Stock·Healthcare - Biotechnology-Activist

CLYM (CLIMB BIO INC) is held by 51 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($77.4M), PRICE T ROWE ASSOCIATES INC /MD/ ($13.1M), MILLENNIUM MANAGEMENT LLC ($8.7M). Net institutional sentiment: Bullish.

51
Holders
(3 Elite)
$145.9M
Total Value
68% (50)
Consensus
34 buying - 16 selling
13F: Insider & Congress:
CLYMSmart Money Verdict
View all
Held by 51 funds
3 elite
Who's Trading
ActivistFMR LLCFMR LLC11.9%Jul 8, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.33.0%Jul 7, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.33.0%Apr 29, 2026
InsiderTBThomas Stephen BasilSell $114KFeb 26, 2026
InsiderTBThomas Stephen BasilSell $236KFeb 25, 2026
ActivistMBMPM BioImpact LLC5.6%Feb 17, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $25KJan 5, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $290KDec 12, 2025
InsiderRLRA CAPITAL MANAGEMENT, L.P.Buy $465KDec 11, 2025
ActivistAEAI ETI LLC0.0%Oct 16, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
11.3M(+0.1%)$77.4M0.8%+23.42%
42
Decreased
1.9M(-0.3%)$13.1M0.0%+226.33%
0
Increased
1.3M(+330.7%)$8.7M0.0%+144.72%
44
New
1.2M$8.1M0.0%+97.46%
38
Increased
773,123(+154.3%)$5.3M0.0%+167.09%
44
Unchanged
600,946$4.1M0.0%+247.39%
0
Increased
401,649(+3.2%)$2.8M0.0%+596.17%
18
Decreased
387,403(-13.0%)$2.7M0.0%+325.30%
0
Increased
345,663(+44.6%)$2.4M0.0%+181.47%
35
Increased
312,999(+0.7%)$2.1M0.0%+127.81%
26
Decreased
310,606(-45.2%)$2.1M0.0%+283.96%
0
Increased
250,102(+1.6%)$1.7M0.0%+216.94%
26
Increased
234,182(+57.7%)$1.6M0.0%+193.05%
37
Decreased
217,300(-32.2%)$1.5M0.0%+548.75%
0
Decreased
171,375(-8.6%)$1.2M0.0%+396.70%
0
New
158,660$1.1M0.0%+97.46%
35
Increased
156,317(+11.2%)$1.1M0.0%+207.99%
28
Decreased
149,970(-33.3%)$1M0.0%+333.77%
0
Increased
132,000(+2.4%)$904,2000.0%+211.42%
17
Increased
127,904(+2.6%)$876,1430.0%+180.89%
25

Showing 1-20 of 54

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used